ISRG
Intuitive Surgical Inc
NASDAQ: ISRG · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$411.06
-0.45% today
Updated 2026-06-12
Market cap
$142.48B
P/E ratio
48.76
P/S ratio
13.46x
EPS (TTM)
$8.25
Dividend yield
—
52W range
$397 – $604
Volume
2.3M
Intuitive Surgical Inc (ISRG) Insider transactions
Net insider activity
Net selling (70,593 shares)
Buy transactions
36
Sell transactions
64
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Sale | 5,625 | — | — |
| 2026-06-01 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Sale | 5,625 | $420.55 | $2.37M |
| 2026-05-22 | BROSIUS, MARK | EVP & Chief Mfg and Supply Cha | Sale | 18 | $439.80 | $7916.40 |
| 2026-05-21 | BROSIUS, MARK | EVP & Chief Mfg and Supply Cha | Sale | 18 | $446.04 | $8028.72 |
| 2026-05-20 | BROSIUS, MARK | EVP & Chief Mfg and Supply Cha | Sale | 18 | $440.38 | $7926.84 |
| 2026-05-19 | BROSIUS, MARK | EVP & Chief Mfg and Supply Cha | Sale | 18 | $440.70 | $7932.60 |
| 2026-05-18 | BROSIUS, MARK | EVP & Chief Mfg and Supply Cha | Sale | 18 | $422.47 | $7604.46 |
| 2026-05-11 | LOEB, GARY | EVP & Chief Legal and Complian | Sale | 400 | $446.95 | $178780.00 |
| 2026-04-30 | REED, MONICA P | Director | Buy | 554 | — | — |
| 2026-04-30 | REED, MONICA P | Director | Sale | 531 | — | — |
| 2026-04-30 | REED, MONICA P | Director | Buy | 531 | — | — |
| 2026-04-30 | NACHTSHEIM, JAMI K | Director | Buy | 554 | — | — |
| 2026-04-30 | NACHTSHEIM, JAMI K | Director | Sale | 531 | — | — |
| 2026-04-30 | NACHTSHEIM, JAMI K | Director | Buy | 531 | — | — |
| 2026-04-30 | LEONARD, KEITH R | Director | Buy | 554 | — | — |
| 2026-04-30 | LEONARD, KEITH R | Director | Sale | 531 | — | — |
| 2026-04-30 | LEONARD, KEITH R | Director | Buy | 531 | — | — |
| 2026-04-30 | LADD, AMY L | Director | Buy | 554 | — | — |
| 2026-04-30 | LADD, AMY L | Director | Sale | 531 | — | — |
| 2026-04-30 | LADD, AMY L | Director | Buy | 531 | — | — |
| 2026-04-30 | KOLLI, SREELAKSHMI | Director | Buy | 554 | — | — |
| 2026-04-30 | KOLLI, SREELAKSHMI | Director | Sale | 531 | — | — |
| 2026-04-30 | KOLLI, SREELAKSHMI | Director | Buy | 531 | — | — |
| 2026-04-30 | JOHNSON, AMAL M | Director | Sale | 531 | — | — |
| 2026-04-30 | JOHNSON, AMAL M | Director | Buy | 531 | — | — |
| 2026-04-30 | GUTHART, GARY S | Director | Buy | 554 | — | — |
| 2026-04-30 | CHEW, LEWIS | Director | Buy | 554 | — | — |
| 2026-04-30 | CHEW, LEWIS | Director | Sale | 531 | — | — |
| 2026-04-30 | CHEW, LEWIS | Director | Buy | 531 | — | — |
| 2026-04-30 | BEERY, JOSEPH C | Director | Buy | 554 | — | — |
| 2026-04-30 | BEERY, JOSEPH C | Director | Sale | 531 | — | — |
| 2026-04-30 | BEERY, JOSEPH C | Director | Buy | 531 | — | — |
| 2026-04-30 | BARRATT, CRAIG H | Director | Buy | 643 | — | — |
| 2026-04-30 | BARRATT, CRAIG H | Director | Sale | 750 | — | — |
| 2026-04-30 | BARRATT, CRAIG H | Director | Buy | 750 | — | — |
| 2026-04-29 | LADD, AMY L | Director | Sale | 119 | $463.50 | $55156.50 |
| 2026-04-28 | LADD, AMY L | Director | Sale | 500 | $473.46 | $236730.00 |
| 2026-03-10 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 105 | — | — |
| 2026-03-10 | CURET, MYRIAM | EVP & Chief Medical Officer | Buy | 105 | $229.39 | $24085.95 |
| 2026-03-09 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 645 | $485.01 | $312831.45 |
| 2026-03-06 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 648 | $490.19 | $317643.12 |
| 2026-03-05 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 648 | $495.20 | $320889.60 |
| 2026-03-04 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 2,362 | $498.68 | $1.18M |
| 2026-03-03 | WIDMAN, FREDRIK | VP Corporate Controller | Sale | 118 | $487.18 | $57487.24 |
| 2026-03-03 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 4,728 | $487.18 | $2.30M |
| 2026-03-03 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 648 | $488.10 | $316288.80 |
| 2026-03-02 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 125 | — | — |
| 2026-03-02 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 125 | $492.59 | $61573.75 |
| 2026-02-28 | WIDMAN, FREDRIK | VP Corporate Controller | Sale | 468 | — | — |
| 2026-02-28 | WIDMAN, FREDRIK | VP Corporate Controller | Buy | 468 | — | — |
| 2026-02-28 | WIDMAN, FREDRIK | VP Corporate Controller | Sale | 233 | $503.51 | $117317.83 |
| 2026-02-28 | SAMATH, JAMIE | EVP & CFO & Enterprise Technol | Sale | 752 | — | — |
| 2026-02-28 | SAMATH, JAMIE | EVP & CFO & Enterprise Technol | Sale | 10,773 | — | — |
| 2026-02-28 | SAMATH, JAMIE | EVP & CFO & Enterprise Technol | Buy | 10,773 | — | — |
| 2026-02-28 | SAMATH, JAMIE | EVP & CFO & Enterprise Technol | Sale | 5,343 | $503.51 | $2.69M |
| 2026-02-28 | SAMATH, JAMIE | EVP & CFO & Enterprise Technol | Buy | 752 | — | — |
| 2026-02-28 | SAMATH, JAMIE | EVP & CFO & Enterprise Technol | Sale | 373 | $503.51 | $187809.23 |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Sale | 1,503 | — | — |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Sale | 9,052 | — | — |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Sale | 14,363 | — | — |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Buy | 14,363 | — | — |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Buy | 9,052 | — | — |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Sale | 7,122 | $503.51 | $3.59M |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Sale | 4,489 | $503.51 | $2.26M |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Buy | 1,503 | — | — |
| 2026-02-28 | ROSA, DAVID J. | Director, Chief Executive Officer (CEO) | Sale | 746 | $503.51 | $375618.46 |
| 2026-02-28 | LOEB, GARY | EVP & Chief Legal and Complian | Sale | 3,148 | — | — |
| 2026-02-28 | LOEB, GARY | EVP & Chief Legal and Complian | Buy | 3,148 | — | — |
| 2026-02-28 | LOEB, GARY | EVP & Chief Legal and Complian | Sale | 1,562 | $503.51 | $786482.62 |
| 2026-02-28 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Sale | 626 | — | — |
| 2026-02-28 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Sale | 8,378 | — | — |
| 2026-02-28 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Buy | 8,378 | — | — |
| 2026-02-28 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Sale | 4,155 | $503.51 | $2.09M |
| 2026-02-28 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Buy | 626 | — | — |
| 2026-02-28 | JEDDI, IMAN | SVP & GM da Vinci Platforms & | Sale | 311 | $503.51 | $156591.61 |
| 2026-02-28 | GUTHART, GARY S | Director | Sale | 2,506 | — | — |
| 2026-02-28 | GUTHART, GARY S | Director | Sale | 26,334 | — | — |
| 2026-02-28 | GUTHART, GARY S | Director | Buy | 26,334 | — | — |
| 2026-02-28 | GUTHART, GARY S | Director | Sale | 13,059 | $503.51 | $6.58M |
| 2026-02-28 | GUTHART, GARY S | Director | Buy | 2,506 | — | — |
| 2026-02-28 | GUTHART, GARY S | Director | Sale | 1,243 | $503.51 | $625862.93 |
| 2026-02-28 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 1,002 | — | — |
| 2026-02-28 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 8,378 | — | — |
| 2026-02-28 | CURET, MYRIAM | EVP & Chief Medical Officer | Buy | 8,378 | — | — |
| 2026-02-28 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 4,155 | $503.51 | $2.09M |
| 2026-02-28 | CURET, MYRIAM | EVP & Chief Medical Officer | Buy | 1,002 | — | — |
| 2026-02-28 | CURET, MYRIAM | EVP & Chief Medical Officer | Sale | 497 | $503.51 | $250244.47 |
| 2026-02-28 | CHARLTON, HENRY L | EVP & Chief Commercial and Mkt | Sale | 752 | — | — |
| 2026-02-28 | CHARLTON, HENRY L | EVP & Chief Commercial and Mkt | Sale | 10,773 | — | — |
| 2026-02-28 | CHARLTON, HENRY L | EVP & Chief Commercial and Mkt | Buy | 10,773 | — | — |
| 2026-02-28 | CHARLTON, HENRY L | EVP & Chief Commercial and Mkt | Sale | 4,800 | $503.51 | $2.42M |
| 2026-02-28 | CHARLTON, HENRY L | EVP & Chief Commercial and Mkt | Buy | 752 | — | — |
| 2026-02-28 | CHARLTON, HENRY L | EVP & Chief Commercial and Mkt | Sale | 335 | $503.51 | $168675.85 |
| 2026-02-28 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 877 | — | — |
| 2026-02-28 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 8,378 | — | — |
| 2026-02-28 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Buy | 8,378 | — | — |
| 2026-02-28 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 4,155 | $503.51 | $2.09M |
| 2026-02-28 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Buy | 877 | — | — |
| 2026-02-28 | BROSIUS, MARK | SVP & Chief Mfg and Supply Cha | Sale | 435 | $503.51 | $219026.85 |
| 2026-02-27 | WIDMAN, FREDRIK | VP Corporate Controller | Sale | 249 | $499.71 | $124427.79 |
Frequently asked questions
Are ISRG insiders buying or selling?
Over the transactions on record, ISRG insiders have been net sellers, with about $34.56M in stock sold across 64 sales, against 1 open-market purchase.
Does insider selling at ISRG mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which ISRG insiders are selling the most?
Recent selling is concentrated in a few names. GUTHART, GARY S accounts for the largest share on record, with about $7.20M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.